abstract |
The specification describes stable non-aqueous polar aprotic formulations of peptide compounds. The non-aqueous polar aprotic solvent is preferably DMSO and the peptide is leuprolide, LHRH, nafarelin or goserelin. They may be stored at elevated temperatures for long periods of time and are especially useful in implantable delivery devices for long term delivery of drug. |